Severe exacerbation of hepatitis B has been reported after stopping treatment with entecavir and hepatic function should be monitored closely, with both clinical and laboratory follow-up for several months after treatment is discontinued. Dosage reduction may be necessary in patients with renal impairment.
Sign Out
